Canada Life
GOSS icon

Canada Life’s Gossamer Bio GOSS Stock Holding History

Canada Life’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,751
Closed -$5K – 2277
2023
Q1 		$5K Sell
3,751
-1,771
-32% -$3.39K ﹤0.01% 2308
2022
Q4 		$12K Buy
5,522
+745
+16% +$6.13K ﹤0.01% 2314
2022
Q3 		$57K Buy
4,777
+848
+22% +$10.5K ﹤0.01% 2078
2022
Q2 		$32K Sell
3,929
-1,418
-27% -$11K ﹤0.01% 2157
2022
Q1 		$49K Buy
5,347
+791
+17% +$7.63K ﹤0.01% 2159
2021
Q4 		$52K Buy
4,556
+772
+20% +$9.17K ﹤0.01% 2156
2021
Q3 		$48K Hold
3,784
– – ﹤0.01% 2246
2021
Q2 		$31K Hold
3,784
– – ﹤0.01% 2396
2021
Q1 		$35K Hold
3,784
– – ﹤0.01% 2404
2020
Q4 		$36K Hold
3,784
– – ﹤0.01% 2390
2020
Q3 		$47K Hold
3,784
– – ﹤0.01% 2193
2020
Q2 		$49K Buy
3,784
+2,854
+307% +$35.9K ﹤0.01% 2225
2020
Q1 		$9K Hold
930
– – ﹤0.01% 2520
2019
Q4 		$14K Buy
+930
New +$18.7K ﹤0.01% 2561
2019
Q3 		– Sell
-3,421
Closed -$76K – 1595
2019
Q2 		$76K Buy
+3,421
New +$65.5K ﹤0.01% 2312

Other funds holding GOSS

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Canada Life's GOSS Position: Q2 2023 in Review

Canada Life sold out of Gossamer Bio (GOSS) in Q2 2023, closing a stake of 3,751 shares — an estimated $5K sold.

Canada Life first reported a position in GOSS in Q2 2019 and held it in 15 quarters. The position peaked at $76K in Q2 2019. 99 funds tracked by Wall St. Rank hold GOSS as of Q2 2023.

  • Canada Life reported no remaining Gossamer Bio position as of Q2 2023 after selling out during the quarter.
  • Canada Life sold 3,751 Gossamer Bio shares in Q2 2023, an estimated $5K.
  • Canada Life first reported a position in Gossamer Bio in Q2 2019 and held it in 15 quarters.
  • Canada Life's Gossamer Bio position peaked at $76K in Q2 2019.
  • 99 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2023.

Based on Canada Life's 13F filing for Q2 2023, filed 10 Aug 2023.